| palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the stockholm infant population, 1999 through 2002. | there are few independent, population-based reports that estimate the risk of hospitalization of respiratory syncytial virus (rsv)-infected infants before and during the palivizumab era. we present figures from the greater stockholm area during the three seasons after the introduction of palivizumab and relate them to data based on 1400 hospitalizations for rsv disease in the same population area during 1987 through 1998. | 2004 | 14743042 |
| respiratory virus infections in stockholm during seven seasons: a retrospective study of laboratory diagnosis. | a retrospective analysis of the virological findings in all respiratory samples (7303) analysed at the laboratory of karolinska hospital between 1993 and 2000 was performed. the findings were studied according to age and seasonal variation, and the methods were evaluated. most samples were from children. rsv was the dominant agent, found in 34% of all samples from children 0-1 y of age. influenza a was found in 13% of samples from the age group 2-5 y. influenza a dominated among adults and the e ... | 2004 | 15307569 |
| molecular epidemiology and genetic variability of respiratory syncytial virus (rsv) in stockholm, 2002-2003. | the epidemiology and genetic variability of circulating respiratory syncytial virus (rsv) strains in stockholm during the season 2002-2003 were studied in consecutive rsv isolates derived from respiratory samples and diagnosed in the laboratory. two hundred thirty-four viruses were sequenced. the samples were mainly from children under 1 year old (79%). the phylogeny of the n-terminal part of the g gene was studied after amplification and sequencing. one hundred fifty-two viruses belonged to sub ... | 2008 | 18041002 |